
Daewoong Pharmaceutical’s Envlo Expands into Seven Latin American and Russian Markets
Daewoong Pharmaceutical's locally developed diabetes treatment, Envlo (active ingredient: Inabogliflozin), is rapidly expanding its presence in the global market. On April 18, Daewoong announced that it has filed for marketing authorization for Enblo …